A single site, open label study to evaluate the pharmacodynamic effects of a single dose of oral anatabine citrate in healthy adult volunteers.
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Anatabine (Primary)
- Indications Alzheimer's disease; Inflammation; Smoking withdrawal; Thyroiditis
- Focus Pharmacodynamics; Proof of concept
- Sponsors Zenith Technology Corporation
- 01 Jul 2015 Results published in a Rock Creek Pharmaceuticals media release.
- 19 Mar 2015 Status changed from active, no longer recruiting to completed, as reported by Australian New Zealand Clinical Trials Registry.
- 12 Mar 2015 New trial record